It’s Time to ‘Be The Match,’ Help Save a Life – SCVNEWS.com

Be the Match: Every three minutes, someone is diagnosed with a life-threatening blood cancer or blood disease, such as leukemia, lymphoma or sickle cell disease, and you might be able to help.

For those thousands, a cure exists, though about 70% of patients dont find it within their own families.

Thats why the College of the Canyons Biology Club is partnering with Be The Match to host a drive-in community registry event, where the community is invited to register to be a potential match for someone in need of a life-saving stem cell transplant through a simple swab test.

The science of stem cells is incredible, and it can actually cure over 70 different life-threatening diseases, said Christine Mantilla, member engagement, enrollment and experience specialist at Be The Match. A small population of stem cells from a donor can regenerate an entire bodys worth of bone marrow.

Biology Club President Brian Estarella-Murphy has been on the registry for two years, eagerly awaiting the day hes a match.

For Estarella-Murphy, its personal, as he has had two close friends with blood disorders and has seen firsthand the struggle of some of these patients.

I interned and shadowed at a hospital and a clinic, he added. Ive seen many patients come in that are on their last chance of life, and Id love to be able to give someone that possibility of living their full life without having to worry.

Being involved with the organization has actually changed his career aspirations, motivating him to go into the research side of medicine.

Im a cellular biology major, and the type of research that they do on these swab tests are exactly what I want to do in the future, he added. I want to pick apart these cells to see how I can help advance medicine (to create) life-saving treatment.

So upon taking up presidency of the club, Estarella-Murphy knew the first thing he wanted to do was partner with Be The Match.

Not only has the current health crisis been an extremely difficult time for those in need of transplants, as they are immunocompromised, but without community registry events, less have been joining.

This is an action that people can take in 10 minutes for free that can directly save someones life, Mantilla said.

Those interested in being a possible match, can drive up to the event from the safety of their car, where volunteers assist them in registering and administering the 10-second swab test on the inner cheeks while following all health and safety measures.

Were just doing a quick, little swab, and then we send your data out, and we do some research to see if youre possibly even a match, Estarella-Murphy said. Our goal out of this event is to sign up as many individuals as possible, so that through further research, we can then match them to patients awaiting dire transfusions.

Only about 1-in-430 U.S. registry members go on to donate bone marrow or peripheral blood stem cells to a patient.

Thats 0.2% and just emphasizes the need for as many people as possible to be available on the registry because it is so challenging to find that match, Mantilla said, adding that not everyone has an equal chance at finding a match, as ethnic heritage plays a significant role. Right now, the registry is overwhelmingly white. Its a health disparity that is pretty serious as far as equity of access to treatment.

The most common way to harvest stem cells is through a peripheral blood stem cell donation, involving a specialized blood draw, where stem cells are processed from your blood before the blood is returned to the donor.

Your stem cells are a renewable resource, so the donors stem cells actually regenerate in about four to six weeks, Mantilla added.

The event is scheduled 2-6 p.m. Aug. 14, with the location to be determined. For more information, visit biologyclubcoc.org/bethematch. To join the registry, visit join.bethematch.org/COCBio or text COCBio to 61474.

View post:
It's Time to 'Be The Match,' Help Save a Life - SCVNEWS.com

Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market 2020 COVID-19 Impact on Industry Size, Share, Company Profiles, Emerging…

Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market 2020 Industry Research Report is an inside-out and expert examination on the flow condition of the Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies industry. In addition to that, this latest investigative report sorts the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market by end client, type, area, and top players/brands. This report further elaborates various factors affecting the market drivers and development. Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market also puts forward insights into market size, crucial markers, review, as well as the most recent net edge, income, types, patterns, along with provincial figure and examination.

Get a Sample PDF of report at https://www.researchreportsworld.com/enquiry/request-sample/15618454

The objective of the study is to define market sizes of different segments and countries in previous years and to forecast the values to the next Five years. The report is designed to incorporate both qualify qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as drivers and restraining factors which will define the future growth of the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market.

To Understand How COVID-19 Impact is Covered in This Report. Get Sample copy of the report at https://www.researchreportsworld.com/enquiry/request-covid19/15618454

The research covers the current Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market size of the market and its growth rates based on 6-year records with company outline of Key players/manufacturers:

Get a Sample Copy of the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Report 2020

Short Description about Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market:

The report also focuses on global major leading industry players of Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. This report focuses on Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Trend, volume and value at global level, regional level and company level. From a global perspective, this report represents overall Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by analyzing historical data and future prospect.

The global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market is anticipated to rise at a considerable rate during the forecast period, between 2020 and 2026. In 2020, the market was growing at a steady rate and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

The Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market is expected to grow at a Highest CAGR during the forecast period 2020-2026.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

Enquire before purchasing this report https://www.researchreportsworld.com/enquiry/pre-order-enquiry/15618454

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies in these regions, from 2020 to 2026, covering

This Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Research/Analysis Report Contains Answers to your following Questions

Purchase this report (Price 3900 USD for single user license) https://www.researchreportsworld.com/purchase/15618454

Major Points from Table of Contents:

1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Revenue 1.4 Market Analysis by Type 1.4.1 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Platelet Rich Plasma Injections 1.4.3 Stem Cell Therapy 1.5 Market by Application 1.5.1 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Share by Application: 2020 VS 2026 1.5.2 Dermatology Clinics 1.5.3 Hospitals 1.6 Coronavirus Disease 2019 (Covid-19): Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Industry Impact 1.6.1 How the Covid-19 is Affecting the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Industry 1.6.1.1 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Business Impact Assessment Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered

2 Global Growth Trends by Regions 2.1 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Perspective (2015-2026) 2.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Growth Trends by Regions 2.2.1 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Historic Market Share by Regions (2015-2020) 2.2.3 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porters Five Forces Analysis 2.3.5 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Growth Strategy 2.3.6 Primary Interviews with Key Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Players (Opinion Leaders)

3 Competition Landscape by Key Players 3.1 Global Top Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Players by Market Size 3.1.1 Global Top Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Players by Revenue (2015-2020) 3.1.2 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Revenue Market Share by Players (2015-2020) 3.1.3 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Concentration Ratio 3.2.1 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Revenue in 2019 3.3 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Key Players Head office and Area Served 3.4 Key Players Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Product Solution and Service 3.5 Date of Enter into Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026) 4.1 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Historic Market Size by Type (2015-2020) 4.2 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Forecasted Market Size by Type (2021-2026)

5 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Breakdown Data by Application (2015-2026) 5.1 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Application (2015-2020) 5.2 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Forecasted Market Size by Application (2021-2026)

6 North America 6.1 North America Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size (2015-2020) 6.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Key Players in North America (2019-2020) 6.3 North America Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Type (2015-2020) 6.4 North America Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Application (2015-2020)

7 Europe 7.1 Europe Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size (2015-2020) 7.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Key Players in Europe (2019-2020) 7.3 Europe Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Type (2015-2020) 7.4 Europe Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Application (2015-2020)

8 China 8.1 China Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size (2015-2020) 8.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Key Players in China (2019-2020) 8.3 China Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Type (2015-2020) 8.4 China Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Application (2015-2020)

9 Japan 9.1 Japan Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size (2015-2020) 9.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Key Players in Japan (2019-2020) 9.3 Japan Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Type (2015-2020) 9.4 Japan Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Application (2015-2020)

10 Southeast Asia 10.1 Southeast Asia Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size (2015-2020) 10.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Type (2015-2020) 10.4 Southeast Asia Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Application (2015-2020)

11 India 11.1 India Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size (2015-2020) 11.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Key Players in India (2019-2020) 11.3 India Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Type (2015-2020) 11.4 India Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Application (2015-2020)

12 Central & South America 12.1 Central & South America Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size (2015-2020) 12.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Key Players in Central & South America (2019-2020) 12.3 Central & South America Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Type (2015-2020) 12.4 Central & South America Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Application (2015-2020)

13 Key Players Profiles 13.1 Orange County Hair Restoration Center 13.1.1 Orange County Hair Restoration Center Company Details 13.1.2 Orange County Hair Restoration Center Business Overview and Its Total Revenue 13.1.3 Orange County Hair Restoration Center Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Introduction 13.1.4 Orange County Hair Restoration Center Revenue in Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Business (2015-2020)) 13.1.5 Orange County Hair Restoration Center Recent Development 13.2 Hair Sciences Center of Colorado 13.2.1 Hair Sciences Center of Colorado Company Details 13.2.2 Hair Sciences Center of Colorado Business Overview and Its Total Revenue 13.2.3 Hair Sciences Center of Colorado Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Introduction 13.2.4 Hair Sciences Center of Colorado Revenue in Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Business (2015-2020) 13.2.5 Hair Sciences Center of Colorado Recent Development 13.3 Anderson Center for Hair 13.3.1 Anderson Center for Hair Company Details 13.3.2 Anderson Center for Hair Business Overview and Its Total Revenue 13.3.3 Anderson Center for Hair Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Introduction 13.3.4 Anderson Center for Hair Revenue in Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Business (2015-2020) 13.3.5 Anderson Center for Hair Recent Development 13.4 Evolution Hair Loss Institute 13.4.1 Evolution Hair Loss Institute Company Details 13.4.2 Evolution Hair Loss Institute Business Overview and Its Total Revenue 13.4.3 Evolution Hair Loss Institute Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Introduction 13.4.4 Evolution Hair Loss Institute Revenue in Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Business (2015-2020) 13.4.5 Evolution Hair Loss Institute Recent Development 13.5 Savola Aesthetic Dermatology Center 13.5.1 Savola Aesthetic Dermatology Center Company Details 13.5.2 Savola Aesthetic Dermatology Center Business Overview and Its Total Revenue 13.5.3 Savola Aesthetic Dermatology Center Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Introduction 13.5.4 Savola Aesthetic Dermatology Center Revenue in Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Business (2015-2020) 13.5.5 Savola Aesthetic Dermatology Center Recent Development 13.6 Virginia Surgical Center 13.6.1 Virginia Surgical Center Company Details 13.6.2 Virginia Surgical Center Business Overview and Its Total Revenue 13.6.3 Virginia Surgical Center Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Introduction 13.6.4 Virginia Surgical Center Revenue in Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Business (2015-2020) 13.6.5 Virginia Surgical Center Recent Development 13.7 Hair Transplant Institute of Miami 13.7.1 Hair Transplant Institute of Miami Company Details 13.7.2 Hair Transplant Institute of Miami Business Overview and Its Total Revenue 13.7.3 Hair Transplant Institute of Miami Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Introduction 13.7.4 Hair Transplant Institute of Miami Revenue in Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Business (2015-2020) 13.7.5 Hair Transplant Institute of Miami Recent Development 13.8 Colorado Surgical Center & Hair Institute 13.8.1 Colorado Surgical Center & Hair Institute Company Details 13.8.2 Colorado Surgical Center & Hair Institute Business Overview and Its Total Revenue 13.8.3 Colorado Surgical Center & Hair Institute Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Introduction 13.8.4 Colorado Surgical Center & Hair Institute Revenue in Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Business (2015-2020) 13.8.5 Colorado Surgical Center & Hair Institute Recent Development

14 Analysts Viewpoints/Conclusions

15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

Continued..

Browse complete table of contents at

https://www.researchreportsworld.com/TOC/15618454

About Us:

Research Reports World is the credible source for gaining the market reports that will provide you with the lead your business needs. At Research Reports World, our objective is providing a platform for many top-notch market research firms worldwide to publish their research reports, as well as helping the decision makers in finding most suitable market research solutions under one roof. Our aim is to provide the best solution that matches the exact customer requirements. This drives us to provide you with custom or syndicated research reports.

CONTACT US

Name: Ajay More

Email:[emailprotected]

Phone:US +1 424 253 0807 /UK +44 203 239 8187

Other Reports Here:

Diphenhydramine Market Research Reports 2020 Global COVID-19 Impact on Industry Size, Share, In-Depth Qualitative Insights, Explosive Growth Opportunity, Regional Analysis by Research Reports World

Global Quasi Continuous Wave (QCW) Lasers Market impact of COVID-19 on Share, Size 2020 Movements by Growth Status, Trend Analysis, Revenue Expectation to 2025 Research Report by Research Reports World

Portable Speakers Market 2020 Covid-19 Impact Analysis on Global Industry Size, Recent Trends, Demand and Share Estimation by 2026 with Top Players ResearchReportsWorld.com

Rehab Equipment Market Covid-19 Impact on Size, share 2020 Global Industry Trends, Growth Drivers, Demands, Business Opportunities and Demand Forecast to 2024

Pocket Filter (ISO16890) Market Size, Share, 2020 Global COVID-19 Impact on Industry Growth, Trends, Emerging Factors, Demands, Key Players, Emerging Technologies and Potential of Industry Till 2025

Emergency Shower & Eye Wash Station Market Share, Size 2020 Global impact of COVID-19 on Industry Forecasts Growth, Analysis, Company Profiles, Competitive Landscape and Key Regions Analysis Available at Research Reports World

Read the original post:
Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market 2020 COVID-19 Impact on Industry Size, Share, Company Profiles, Emerging...

Shady Stem Cell Therapies Can Cause Tumors, Infections, and Death, Doctors Report – Gizmodo

A researcher holding up a container of stem cells.Photo : Spencer Platt (Getty Images )

A team of neurologists are raising a red flag over risky and unproven stem cell therapies. Their new study suggests that their fellow doctors are frequently asked about these controversial procedures by desperate patients. Many doctors are also seeing patients with serious complications from stem cell therapy, including seizures, infections, and spinal tumors.

Stem cells are the raw material that our body uses to replace other damaged or aging cells. Scientists have been hopeful about the potential to use these cells as a way to surpass the bodys natural regenerative ability and treat currently incurable diseases, including degenerative neurological disorders like multiple sclerosis.

But so far, there are only a few proven uses in medicine for stem cells, such as bone marrow transplants to treat certain blood cancers. Most of the evidence for their claimed benefits elsewhere is either limited or entirely lacking. These caveats havent stopped the consumer stem cell industry from growing, though, with clinics offering treatments on an experimental basis, often without express approval from the Food and Drug Administration.

This new study, published Wednesday in the Annals of Neurology, was a survey of over 200 neurologists across the country, including a third who specialize in multiple sclerosis. Among other questions, the neurologists were asked if they had ever come across patients who had used or wanted to use stem cells to treat their health problems. For those with patients previously given stem cells, they were also asked about any health complications they had seen that were possibly linked to stem cell treatment.

G/O Media may get a commission

BLEU by Rod Beattie Cover-Up Caftan

Almost 90% of the neurologists surveyed said they had been asked by a patient or a close family member about stem cells, a rate that was slightly higher for those with patients who had incurable conditions like multiple sclerosis. Many of those conversations involved patients asking for the neurologists blessing to go ahead with stem cell therapy. But only 28% of the doctors reported feeling completely prepared to talk to their patients about the topic.

One of the studys points is that these discussions are happening in more than 90% of every outpatient neurology clinic, but many of the doctors are not ready, said senior author Jamie Imitola, a neuroscientist at the University of Connecticut who specializes in multiple sclerosis and stem cell research. And if theyre not fully prepared, then thats shocking, because these are the doctors that should be up to date.

Two-thirds of neurologists also said they had treated someone who had already gotten a stem cell therapy, while 25% of respondents said they had come across a patient with complications thought to be related to a stem cell therapy. Some of the specific complications listed have been reported before, but Imitola said the percentage of doctors who reported any at all is much higher than you would expect from the small number of case reports available. It suggests that side-effects linked to these procedures may be more common than previously thought.

Ive had doctors call us and tell us that patients dont want to report problems with their stem cell treatment, he added. They feel embarrassed, number one, because they have a complication or two, because they feel they were ripped off.

The long list of complications reported by doctors in the survey included stroke, paralysis, bloodborne infections like hepatitis C, and several deaths. In two cases, doctors reported the emergence of a tumor along the spinal cord; in one case, the tumor had cells that didnt seem to belong to the patient, suggesting the donors cells had somehow turned cancerous. In other cases, the therapy seemed to worsen the progression of the disease it was meant to treat. Still other patients had spent tens of thousands of dollars on their treatment, with no lasting improvement.

The surveys findings are limited, especially when it comes to the reported complications, since theyre reliant on the recollection of doctors rather than medical records or other verified information. But the study points to all sorts of systemic problems, Imitola said. Many of these patients are understandably looking for a miracle, and theres a growing mistrust of science in general, he noted. That makes the wondrous claims peddled by many clinics selling stem cell therapy look all the more appealing. And it makes the relationship between a doctor and their patient all the more important to get right.

There is a sense around the country that scientists are hiding new therapies for this or that. That we dont want people to get stem cell therapy, because there is some ulterior motive, he said. The reality is that for us to translate stem cells into something real, its going to require a great deal of work. Because, ultimately, we want to provide people the best therapy, the best opportunities.

To help neurologists be more prepared to talk about stem cells, the researchers have created a patient-friendly handout based on their findings, translated into 17languages. Imitola has also set up a patient registry where doctors and patients can anonymously report any possible complications linked to stem cell therapy.

Read more:
Shady Stem Cell Therapies Can Cause Tumors, Infections, and Death, Doctors Report - Gizmodo

Digong forgot to mention the cure for Covid-19 The Manila Times – The Manila Times

ONE of the highlights in President Rodrigo Digong Dutertes fifth State of the Nation Address (SONA) was his proposal to Congress to revive the death penalty through lethal injection.

The death penalty law was passed during the term of President Fidel Ramos, but was scrapped by President Gloria Macapagal Arroyo, who gave in to pressure from the Catholic Church.

The death penalty could decrease the commission of heinous crimes.

Digong said drug offenses would be covered by his proposed death penalty.

But how about rape with homicide, rape of a minor, murder, robbery with homicide and large-scale estafa?

How about law enforcers who commit grave offenses using their badges as a shield? Among the serious crimes by law enforcers is planting evidence on innocent citizens.

How about government officials who coddle big-time criminals?

The above-cited offenses should have been included by Digong as punishable by lethal injection.

If Congress considers the Presidents proposal to restore the death penalty, it should include the other heinous crimes mentioned above.

* * *

Congress should not listen to bleeding hearts like Amnesty International since they refuse to see the real crime situation in the Philippines.

Bleeding hearts were not able to stop the death penalty in many countries, including some states in the United States.

Why should they stop our country from restoring the death penalty?

* * *

I was expecting the President to announce the discovery by Filipino doctors of a cure for seriously ill coronavirus disease 2019 (Covid-19) patients in the SONA.

The citizenry, cowering in fear of the dreaded illness, would have appreciated the Presidents speech more if he had included the medical breakthrough.

The medical breakthrough was announced by Palace spokesman Harry Roque Jr. in a virtual press conference in Malacaang several days before the SONA.

However, the story was buried in the inside pages of major newspapers, a treatment it did not deserve.

The discovery of the cure for Covid-19 was made by scientists at The Medical City hospital through its Institute of Molecular Medicine stem cell program.

Stem cells taken from the blood of preserved umbilical cords worked their magic on six patients about to be intubated through intravenous injections.

I wrote about the medical breakthrough in my column last Tuesday, July 28.

For those who missed that column, you may want to read it at the Manilatimes.net.

* * *

A big supply of umbilical cords would bring down the cost of the stem cell therapy for Covid-19.

Tens of thousands of women give birth in the country and the umbilical cords of the newborns are thrown away.

The possible sources of umbilical cords are government hospitals and paanakan (maternity) centers.

The Philippines is a big manufacturer of babies.

Proof is that for a small country, our population has ballooned to 110 million.

To digress, I was a medical representative (detailman) in 1973 and one of the hospitals in Metro Manila that I was assigned to cover was the Fabella Memorial Hospital, a maternity hospital, in Sta. Cruz, Manila.

As I was fixing the promotional medicines I would give to some doctors at Fabella, I heard the screams of pain by a woman about to give birth at the delivery room.

Armando, Armando! P****g i*a mo! the woman was shouting, apparently referring to her husband.

I heard the nurse or midwife tell the woman, Tumigil ka nga diyan! Huwag mong sisihin ang asawa mo. Taun-taon nandito ka (Shut up! Dont blame your husband. Youre here every year).

See what I mean by the country being a manufacturing center of babies?

* * *

Another highlight of the Presidents SONA was his plan to establish the Coconut Farmers Trust Fund.

That part of Digongs speech was near to my heart as I come from Davao Oriental, a province where the main livelihood of the people is harvesting coconuts and turning them into copra.

Coconut farmers are the poorest in the country.

It was not so before, say, in the 1960s, when the price of copra was very high and coconut farmers in my hometown Manay could send their children to very good schools in Davao City and elsewhere.

But the price of copra in the world market is now very low and Filipino coconut farmers have become impoverished as a result.

However, the dying coconut industry might soon come to life again and the farmers could be rich once more.

An American friend of mine, Matt Grecsec, has invented a machine that converts coconut husk into hardwood for construction materials.

Grecsec, whos from Florida and married to a Filipina, has been coming to the Philippines looking for a place to set up his plant to make hardwood out of coconut husk.

Coconut husk is thrown away by farmers who make copra.

Grecsec has been meeting with Agriculture Secretary William Dar who has expressed enthusiasm for his project.

The rest is here:
Digong forgot to mention the cure for Covid-19 The Manila Times - The Manila Times

$30+ Billion Cell Expansion Market by Product, Cell Type, Application, End-user and Region – Forecast to 2025 – ResearchAndMarkets.com – Yahoo Finance

The "Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research), End-User, and Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global cell expansion market is projected to reach USD 30.06 billion by 2025 from an estimated USD 14.91 billion in 2020, at a CAGR of 15.1%.

The report segments the cell expansion market based on region (Asia Pacific, Europe, North America, and RoW), product (consumables and instruments), cell type (human cells and animal cells), application (regenerative medicine and stem cell research, cancer and cell-based research and other applications), and end user (research institutes, biotechnology and biopharmaceutical companies, cell banks, and other end users). The report also provides a comprehensive review of market drivers, restraints, and opportunities in the cell expansion market.

Increasing incidence of chronic diseases and government investments for cell-based research are set to drive the cell expansion market

Growth in this market is largely driven by the increasing incidence of chronic diseases, government investments for cell-based research, growing focus on personalized medicine, increasing focus on R&D for cell-based therapies, and increasing GMP certifications for cell therapy production facilities. On the other hand, ethical concerns regarding research in cell biology are expected to limit market growth to a certain extent in the coming years.

By instruments type, the cell expansion supporting equipment accounted for the fasted growing product segment of the cell expansion market

The instruments segment includes cell expansion supporting equipment, bioreactors, and automated cell expansion systems. The cell expansion supporting equipment market includes flow cytometers, cell counters and hemocytometers, centrifuges, and other supporting equipment. They are used in cell culture processes for isolating, culturing, scaling-up, and extracting biological products. These instruments are essential in laboratories and institutes for conducting research and analyzing the cell structure and function for cell therapy research.

By cell type, the human cells segment accounted for the largest share of the cell expansion market

Based on cell type, the cell expansion market is segmented into human cells and animal cells. The human cells segment includes stem cells and differentiated cells. The stem cells segment is further classified into adult stem cells, ESCs, and iPSCs. The human cells segment accounted for the larger share of the cell expansion market majorly due to the increasing investments by public and private organizations for research on human cells, growing application areas of human stem cells, and the growing incidence of diseases such as cancer.

Asia Pacific: The fastest-growing region in the cell expansion market

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to the increasing focus of players on emerging Asian markets, increasing incidence of chronic and infectious diseases, rising geriatric population, and government initiatives for infrastructural improvements of healthcare facilities are driving the growth of the cell expansion market in this region.

North America: the largest share of the cell expansion market

North America accounted for the largest share of the cell expansion market. The large share of this segment can primarily be attributed to the rising incidence of cancer, increasing government funding, rising research activates on stem cell therapies, growing awareness regarding advanced treatment methods, growing geriatric population, and the strong presence of industry players in the region.

Company Profiles

Established Companies

Start-up Companies

For more information about this report visit https://www.researchandmarkets.com/r/y35ufs

View source version on businesswire.com: https://www.businesswire.com/news/home/20200729005450/en/

Contacts

ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Follow this link:
$30+ Billion Cell Expansion Market by Product, Cell Type, Application, End-user and Region - Forecast to 2025 - ResearchAndMarkets.com - Yahoo Finance

Dreambody.clinic – Stem Cells, HGH, TRT, Hormone …

Mesenchymal Stem Cell Therapy

At Dream Body Clinic we offer Mesenchymal Stem Cell Therapy Treatments for Autoimmune disorders, Chronic Degenerative disorders, Articulations, Cosmetic Issues and more.

Our Mesenchymal Stem Cells are derived from Umbilical cord (Wharton Jelly) and Placenta. All donors are under 30 years old and put through a stringent screening process to ensure we only have gold quality stem cells. This tissue that we derive from is the youngest possible source for stem cells. This means that the stem cells we administer are as young and healthy as possible. There is no chance of rejection as mesenchymal stem cells lack human leukocyte antigen (HLA). HLA is what the immune system looks for to detect intruders. Our stem cells are sourced in the best way possible and then cultivated to provide the tens of millions or hundreds of millions of stem cells needed for a successful stem cell therapy.

Our Mesenchymal Stem Therapy Treatments have many anti-aging benefits. We are able to effect the whole body with a stem cells anti-aging IV Treatment or focus on specific areas like the face or hair. The stem cells target inflammation and then fix the route cause. Chronic inflammation always speeds up aging so this is the first way anti-aging stem cells effect. Next they donate mitochondria to weak cells. The mitochondria are like the engines of the cells and by having fresh, new mitochondria they have more energy and work better. The stem cells have also been found to extend telomere length in at least 6 types of cells. It is believed that research will show they do this for even more cells. The stem cell facial treatment is able to restore collagen and fat below the surface of the skin. This fills in the lines and restores a youthful appearance. It also improves skin quality and thickness. The Stem Cell Hair Restoration Treatment allows hair follicles that are closing to re-open. They also help regenerate the existing hair. stem cell therapy for anti-aging is wonderful

Our Diabetes Stem Cell Treatment is extremely effective at mitigating the negative effects of Type 2 diabetes. The mesenchymal stem cell treatment for Type 2 diabetes is an IV of 300 Million mesenchymal stem cells. These stem cells send out cytokines that effectively reprogram the immune system to protect the pancreas instead of attacking it. This leads to stabilized blood glucose levels and proper insulin response. A proper diet with low sugar and low fast carbohydrates is needed to maintain results, but the stem cell treatment has a profound effect on Type 2 diabetes. Learn more about our Type 2 Diabetes Stem Cell Therapy.

Our Lyme Disease Stem Cell Treatment is extremely effective at mitigating the negative effects of Lyme disease. The mesenchymal stem cell treatment for Lyme disease is an IV of 300 Million mesenchymal stem cells. These stem cells send out cytokines that effectively reprogram the immune system to protect the body instead of attacking it. This leads to feeling normal again. Learn more about our Lyme Disease Stem Cell Treatment.

Our HGH Legal Fly & Buy Program is our longest running program that we have been doing for 8 years. It is legal to seek medical treatment abroad and return home with any prescribed medication. We start with a blood panel to make sure you are healthy and then prescribe the HGH to meet your country of origins law. For the USA that is 50 dose units and the rest of the world is a 90 day supply. We can legally send you home with up to 720 IU of pharmaceutical HGH like Norditropin HGH, Genotropin HGH or Humatrope HGH. That is enough for 2IU a day for a year. Learn more about our HGH Legal Fly & Buy Program.

Our Genotropin HGH Legal Fly & Buy Program is the best. We can legally send you home with up to 720 IU of Genotropin HGH. Enough for 2IU a day for a year. Buy HGH the legal way. Learn more about our Genotropin HGH Legal Fly & Buy Program.

Our Norditropin HGH Legal Fly & Buy Program is the best. We can legally send you home with up to 720 IU of Genotropin HGH. Enough for 2IU a day for a year. You can now buy HGH Legally! Learn more about our Norditropin HGH Legal Fly & Buy Program.

Our Humatrope HGH Legal Fly & Buy Program is the best. We can legally send you home with up to 720 IU of Humatrope HGH. Enough for 2IU a day for a year. You can finally buy HGH Legally! Learn more about our Humatrope HGH Legal Fly & Buy Program.

Our Testosterone Replacement Therapy TRT Legal Fly & Buy Program is the best. We can legally send you home with up to 100ml of Testosterone. That is enough to last 2 years at 1ml a week. You can finally buy TRT at the dose you want Legally! Learn more about our Testosterone Replacement Therapy TRT Legal Fly & Buy Program.

Our Proviron Legal Fly & Buy Program is the best. We can legally send you home with up to 80 boxes of proviron. You can finally buy Proviron at the dose you want Legally! Learn more about our Proviron Legal Fly & Buy Program.

Our Deca Durabolin Legal Fly & Buy Program is the best. We can legally send you home with up to 50 boxes of Deca Durabolin. You can finally buy Deca Durabolin at the dose you want Legally! Learn more about our Deca Durabolin Legal Fly & Buy Program.

Our Anavar (Oxandralone) Legal Fly & Buy Program is the best. We can legally send you home with up to 6 bottles of Anavar (Oxandralone). You can finally buy Anavar (Oxandralone) at the dose you want Legally! Learn more about our Anavar (Oxandralone) Legal Fly & Buy Program.

Our Modafinil Legal Fly & Buy Program is the best. We can legally send you home with up to 8 boxes of Modafinil. You can finally buy modafinil at the dose you want Legally! Learn more about our Modafinil Legal Fly & Buy Program.

See more here:
Dreambody.clinic - Stem Cells, HGH, TRT, Hormone ...

Family need to raise 120K by September for lifesaving treatment for 11-year-old – Cheshire Live

The family of a brave 11-year-old Wistaston boy needs to raise 120,000 by September so he can have lifesaving treatment in Asia to stop a rare form of bone cancer returning.

Georgy Capener was diagnosed with the highly malignant Ewings Sarcoma after a fall in a friends back garden on Easter Sunday in 2018.

Since then the plucky Wistaston Church Lane pupil has undergone numerous rounds of high dose aggressive chemotherapy and radiotherapy.

As a result of the treatment he lost his right arm which has been replaced a titanium prosthesis.

Georgy went into remission in March of last year and life returned to a semblance of normality for the Crewe boy, his mum Helen, dad Richard, and sisters Ellie, 18, and Chloe, 13.

But in April this year the family were dealt another devastating blow when they learned the cancer had returned - this time in Georgys left sinus, just under his eye socket and in the back of his nose.

Helen told CheshireLive: Everything had been going really well and then there was the impact of the coronavirus pandemic so one scan [to check Georgy] was moved further on but we never got to it because he started having really painful headaches. I knew something wasnt right.

Georgys parents were told that, because of the location of the tumour, there was a chance he could lose his eyesight or suffer a stroke during the biopsy he needed.

Helen told how, at first, she didnt want him to have the biopsy, but she knew he had to.

We didnt know if he was going to come out with his eyesight or have a stroke but he came through it, she said. Hes so brave, hes been so brave throughout.

Georgy, who is a passionate Liverpool fan, is now undergoing chemotherapy and radiotherapy again.

The tumour cannot be removed surgically because of its location.

But the vital stem cell therapy which is essential to ensure he can live a normal, healthy life and prevent the cancer returning at a later stage costs 130,000 and is not available for Georgy on the NHS.

Helen said: After lengthy discussions with a stem cell transplant hospital in a top medical treatment centre in Thailand, we are thrilled that they are willing to accept Georgy.

The transplant will involve removing the faulty mother cell and harvesting new purified cells from a donated umbilical cord into his body to stop the cancer from returning. These procedures have very high success rates.

Georgy is due to finish his sixth and final round of chemotherapy at the beginning of September.

For the stem cell treatment to be successful the procedure would have to start immediately after that to ensure the cancer doesnt return straight away.

The family has set up a JustGiving appeal to raise the funds needed to save their little boys life. They need to raise 120,000 by the beginning of September.

Helen said: We set it up in the hope that we can raise some of this amount to help save our sons life. It is our only realistic option and, for the first time in a long time, we can be positive and see some sort of future.

If you can help please donate by visiting JustGiving here.

See the original post:
Family need to raise 120K by September for lifesaving treatment for 11-year-old - Cheshire Live

Global trade impact of the Coronavirus Synthetic Stem Cells Market Report 2020-2026 Research Insights 2020 Global Industry Outlook Shared in Detailed…

Synthetic Stem Cells Market report covers the Introduction, Product Type and Application, Market Overview, Market Analysis by Countries, Market Opportunities, Market Risk and Market Driving Force. Under Coronavirus (COVID19) outbreak globally, this Synthetic Stem Cells industry report provides 360 degrees of analysis from Supply Chain, Import and Export control to regional government policy and future influence on the industry.Focuses on the topmost key Synthetic Stem Cells market manufactures/players like(North Carolina State University, Zhengzhou University), to define, describe and analyze the Sales Volume, Value, Market Share, Capacity, Production, Price, Revenue, Cost, Gross, Gross Margin, Synthetic Stem Cells Market Competition Landscape, SWOT Analysis and Development Plans in next few years.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures)of Synthetic Stem Cells[emailprotected]https://www.researchmoz.us/enquiry.php?type=S&repid=2395700

Which Prime Data Figures are Included in This Synthetic Stem Cells Market Report-Market size (Last few years, current and expected); Market share analysis as per different companies; Synthetic Stem Cells Market forecast; Demand; Price Analysis; Synthetic Stem Cells Market Contributions (Size, Share as per regional boundaries).

Scope of Synthetic Stem Cells Market:Synthetic stem cells offer therapeutic benefits comparable to those from natural stem cells and could reduce some of the risks associated with stem cell therapies. Additionally, these cells have better preservation stability and the technology is generalizable to other types of stem cells.

On the basis on the end users/applications,this report focuses on the status and outlook for major applications/end users, shipments, revenue (Million USD), price, and market share and growth rate foreach application.

Cancers Wounds and Injuries Musculoskeletal Disorders Blood disorders

On the basis of product type, this report displays the shipments, revenue (Million USD), price, and market share and growth rate of each type.

Cardiovascular Diseases Neurological Disorders Other Diseases

Do You Have Any Query Or Specific Requirement? Ask to Our Industry[emailprotected]https://www.researchmoz.us/enquiry.php?type=E&repid=2395700

Synthetic Stem Cells Market Regional Analysis Covers:

Some Important Highlights From The Synthetic Stem Cells Market Report Include:

To Get Discount of Synthetic Stem Cells Market:https://www.researchmoz.us/enquiry.php?type=D&repid=2395700

Contact:

ResearchMoz Mr. Rohit Bhisey, Tel: +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 Email:[emailprotected]

Browse More Reports Visit @https://www.mytradeinsight.blogspot.com/

Go here to see the original:
Global trade impact of the Coronavirus Synthetic Stem Cells Market Report 2020-2026 Research Insights 2020 Global Industry Outlook Shared in Detailed...

Orthopedic Regenerative Medicine Market Insights and Business Outlook By Top Players Curasan, Inc., Carmell Therapeutics Corporation, Anika…

A new business intelligence report released by CMI with title GlobalOrthopedic Regenerative Medicine MarketResearch Report 2019-2027 is designed covering micro level of analysis by manufacturers and key business segments. The Global Orthopedic Regenerative Medicine Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary statistics sources and it comprises both qualitative and quantitative detailing. Some of the key players profiled in the study are Curasan, Inc., Carmell Therapeutics Corporation, Anika Therapeutics, Inc., Conatus Pharmaceuticals Inc., Histogen Inc., Royal Biologics, Ortho Regenerative Technologies, Inc., Swiss Biomed Orthopaedics AG, Osiris Therapeutics, Inc., and Octane Medical Inc.

Whats keeping Curasan, Inc., Carmell Therapeutics Corporation, Anika Therapeutics, Inc., Conatus Pharmaceuticals Inc., Histogen Inc., Royal Biologics, Ortho Regenerative Technologies, Inc., Swiss Biomed Orthopaedics AG, Osiris Therapeutics, Inc., and Octane Medical Inc. Ahead in the Market? Benchmark yourself with the strategic moves and findings recently released by CMI

Leading players of Orthopedic Regenerative Medicine Market:

Curasan, Inc., Carmell Therapeutics Corporation, Anika Therapeutics, Inc., Conatus Pharmaceuticals Inc., Histogen Inc., Royal Biologics, Ortho Regenerative Technologies, Inc., Swiss Biomed Orthopaedics AG, Osiris Therapeutics, Inc., and Octane Medical Inc.

Orthopedic Regenerative Medicine Geographical Segmentation Includes:

North America (U.S., Canada, Mexico)

Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)

Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)

Latin America (Brazil, Rest of L.A.)

Middle East and Africa (Turkey, GCC)

The research report includes an exploration of the competitive landscape present in the Orthopedic Regenerative Medicine Market. It includes an import of the current and future trends that players can invest in. Likewise, it also includes an estimation of the business outlooks of the players and explains the nature of the competition.

Orthopedic Regenerative Medicine Market Segmentation

By Procedure Cell TherapyTissue EngineeringBy Cell TypeInduced Pluripotent Stem Cells (iPSCs)Adult Stem CellsTissue Specific Progenitor Stem Cells (TSPSCs),Mesenchymal Stem Cells (MSCs)Umbilical Cord Stem Cells (UCSCs)Bone Marrow Stem Cells (BMSCs)By SourceBone MarrowUmbilical Cord BloodAdipose TissueAllograftsAmniotic FluidBy ApplicationsTendons RepairCartilage RepairBone RepairLigament RepairSpine RepairOthers

The plus point of this research study is that it includes the impact of COVID-19 to the Orthopedic Regenerative Medicine market. The data summarized within this research study includes forecast from 2020 to 2027. COVID-19 has significantly impacted each and every market on the global platform. If you have any specific requirement then Please get in touch with us. Our Expert team will provide as per report customized to your requirement.

Important Features of the report:

Reasons for buying this report:

It offers the regional analysis of the Orthopedic Regenerative Medicine Market along with the business profiles of several stakeholders.

Some Major TOC Points:

Chapter 1. Orthopedic Regenerative Medicine Market Report Overview

Chapter 2. Orthopedic Regenerative Medicine industry Growing Trends

Chapter 3. Market Share by Key vendors

Chapter 4. Orthopedic Regenerative Medicine Market Breakdown Data by Type and Application

Chapter 5. Orthopedic Regenerative Medicine Market by End Users/Application

Chapter 6. COVID-19 Outbreak: Orthopedic Regenerative Medicine Industry Impact

Chapter 7. Opportunity Analysis in Covid-19 Crisis

Chapter 9. Market Driving Factors

And Many More

Apply Promo Code CMIFIRST1000 And Get Instant Discount OfUSD 1000

Download PDF Brochure Of this Report @https://www.coherentmarketinsights.com/insight/request-pdf/3566

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, LATAM, West Europe, MENA Countries, Southeast Asia or Asia Pacific.

About us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contacts US

Mr. Shah US +1-206-701-6702/UK +44-020 8133 4027 Email: [emailprotected]arketinsights.com

More here:
Orthopedic Regenerative Medicine Market Insights and Business Outlook By Top Players Curasan, Inc., Carmell Therapeutics Corporation, Anika...

Books: Five new books to read this week – HeraldScotland

All The Lonely People by Mike Gayle is published in hardback by Hodder & Stoughton, priced 14.99 (ebook 4.99)

Hubert Bird is old and lonely. In weekly phone calls to his daughter Rose, who lives in Australia, he paints the picture of a perfect busy retirement, filled with friends and outings, when the reality is anything but. When Rose announces she is coming to stay, he realises he needs to make some changes. A young mother moves into the neighbourhood and the pair strike up an unlikely friendship as they start a campaign to tackle loneliness in the area. This timely and poignant book flits between present day and Hubert's early life, emigrating to the UK as one of the Windrush generation. Mike Gayle's writing is beautiful and engaging and All The Lonely People is both heartbreaking and uplifting, devastating and thought-provoking. It is the kind of book you will want to press into the hands of everyone you know and tell them to read immediately.

All Adults Here by Emma Straub is published in hardback by Michael Joseph, priced 14.99 (ebook 9.49)

The challenging journey through adulthood is explored with perceptive wit in Emma Straub's entertaining new novel. All Adults Here charts the complicated relationships of the Strick family in the fictional small US town of Clapham. At its heart is family matriarch Astrid, who witnesses a shocking tragedy that sparks a re-examination of her life. As she opens up to her adult children - frustrated Elliott, single-mum-to-be Porter and bohemian Nicky - it turns out they also have secrets and hang-ups to spill. Straub endearingly portrays her central characters as they tangle with a multi-generational crew of friends and relatives. Her easy writing style combines wry humour with the occasional poignant insight. At times the comic tone feels jarring when the novel addresses more serious themes, skipping too lightly over a character's inner complexities. But this is a book that whips along with feel-good momentum, driven by warmth and love.

Pondweed by Lisa Blower is published in hardback by Myriad Editions, priced 12.99 (ebook 5.58)

Lisa Blower is a highly-regarded short-story writer, and her new novel tells the story of an unlikely road trip undertaken by two endearing and idiosyncratic people. Pondweed centres on a couple of late 60-somethings, Selwyn and Ginny. Next-door neighbours in their youth, they once courted and have now got together again - after a fashion-following a 50-year interval. They think they know each others' distant pasts intimately - but are not so strong on anything since. In the interim, Ginny had a daughter and not much else happened for her; Selwyn developed his passion for ponds. But cheated by his business partner out of his pension, Selwyn decides to take the pair of them off on a trip down memory lane in the direction of Wales, armed only with a stolen caravan full of booze and ornamental fish. The road trip quickly turns out to be a painful, poignant and charming journey through the couple's past, as a series of apparently impromptu stop-offs start to trigger forgotten memories, unresolved conflicts, and only partially buried secrets. An unlikely romance between two people who are meant for each other, but don't know how to be together, Pondweed is a delightful read.

Sex Robots & Vegan Meat by Jenny Kleeman is published in hardback by Picador, priced 12.99 (ebook 8.99)

Synthetic wombs, do-it-yourself euthanasia, AI sex robots and meat grown from stem cells: are these the plots of dystopian horror movies or the technologies that will save the future of humankind? Documentary film-maker and journalist Jenny Kleeman explores birth, death, sex and food, navigating opinions, facts and half-truths. In doing so, she must negotiate with an array of distinctive characters (including evangelistic vegans, competitive scientists, and even incels), all of whom vie for centre stage. The real treat is Kleeman's insatiable curiosity, pushing her to ask the difficult questions, even when conversations take an awkward turn (as they so often do). Coupled with her own knee-jerk emotions, assumptions and personal views, her narration ends up being part fact-finding mission, part-storytelling. Whether she's right or wrong isn't really the point; it's whether you agree, disagree, or are downright horrified by the promises of this whole new world. A moreish page-turner of a book that will leave you feeling informed and ready for the next dinner party.

Children's book of the week

The Secret Explorers and the Comet Collision is published in hardback by DK, priced 15.31 (ebook 2.99)

Space and the universe are the setting for the first instalment of DK's new educational series for children, which introduces us to the Secret Explorers, a team of elite mini adventurers. Each of the eight explorers has a unique expertise and has been brought together from around the world to solve special secret missions. In Comet Collision - one of two initial books in the series - space whiz Roshni and rain forest expert Ollie are picked to blast off for a mission to Jupiter to fix a broken space probe. We see Roshni go on a daring spacewalk as the duo work against the clock to complete their mission before a comet strikes. From facts about Jupiter's rings and space probes to asteroids and gravity, the story is perfect for little stargazers aged seven and above, though it can be a little clunky at times during the educational bits.

See the original post:
Books: Five new books to read this week - HeraldScotland